Order Article Reprints

Abo El-Enin HA, Mostafa RE, Ahmed MF, Naguib IA, A. Abdelgawad M, Ghoneim MM, Abdou EM. Assessment of Nasal-Brain-Targeting Efficiency of New Developed Mucoadhesive Emulsomes Encapsulating an Anti-Migraine Drug for Effective Treatment of One of the Major Psychiatric Disorders Symptoms. Pharmaceutics. 2022; 14(2):410. https://doi.org/10.3390/pharmaceutics14020410

Abo El-Enin, Hadel A., Rasha E. Mostafa, Marwa F. Ahmed, Ibrahim A. Naguib, Mohamed A. Abdelgawad, Mohammed M. Ghoneim, and Ebtsam M. Abdou. 2022. "Assessment of Nasal-Brain-Targeting Efficiency of New Developed Mucoadhesive Emulsomes Encapsulating an Anti-Migraine Drug for Effective Treatment of One of the Major Psychiatric Disorders Symptoms" Pharmaceutics 14, no. 2: 410. https://doi.org/10.3390/pharmaceutics14020410

Abo El-Enin, H. A., Mostafa, R. E., Ahmed, M. F., Naguib, I. A., A. Abdelgawad, M., Ghoneim, M. M., & Abdou, E. M. (2022). Assessment of Nasal-Brain-Targeting Efficiency of New Developed Mucoadhesive Emulsomes Encapsulating an Anti-Migraine Drug for Effective Treatment of One of the Major Psychiatric Disorders Symptoms. Pharmaceutics, 14(2), 410. https://doi.org/10.3390/pharmaceutics14020410